Cytochrome P450 Enzymes: |
---|
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
BP | GO:0050896; response to stimulus | GO:0042738; exogenous drug catabolic process | 1.789E-11 | 9.739E-08 | CYP1A2, CYP2C19, CYP2C9, CYP3A4 |
BP | GO:0008152; metabolic process | GO:0070989; oxidative demethylation | 1.789E-11 | 9.739E-08 | CYP1A2, CYP2C9, CYP2D6, CYP3A4 |
BP | GO:0008152; metabolic process | GO:0006805; xenobiotic metabolic process | 1.613E-09 | 3.025E-06 | CYP1A2, CYP2C19, CYP2C9, CYP2D6, CYP3A4 |
BP | GO:0008152; metabolic process | GO:0097267; omega-hydroxylase P450 pathway | 1.197E-08 | 1.241E-05 | CYP1A2, CYP2C19, CYP2C9 |
BP | GO:0008152; metabolic process | GO:0019373; epoxygenase P450 pathway | 1.322E-07 | 1.152E-04 | CYP1A2, CYP2C19, CYP2C9 |
BP | GO:0008152; metabolic process | GO:0009822; alkaloid catabolic process | 7.235E-07 | 5.251E-04 | CYP2D6, CYP3A4 |
BP | Unclassified; | GO:0021853; cerebral cortex GABAergic interneuron migration | 2.410E-06 | 1.500E-03 | DRD1, DRD2 |
BP | GO:0023052; signaling | GO:0051584; regulation of dopamine uptake involved in synaptic transmission | 6.743E-06 | 3.415E-03 | DRD1, DRD2 |
BP | GO:0032501; multicellular organismal process | GO:0030432; peristalsis | 1.083E-05 | 5.127E-03 | DRD1, DRD2 |
BP | GO:0032502; developmental process | GO:0021756; striatum development | 1.323E-05 | 6.132E-03 | DRD1, DRD2 |
Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|
hsa00140 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 3.664E-04 | 1.420E-03 | CYP1A2; CYP3A4 |
hsa00232 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.498E-03 | 5.531E-03 | CYP1A2 |
hsa00380 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.983E-02 | 3.414E-02 | CYP1A2 |
hsa00590 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 4.187E-04 | 1.442E-03 | CYP2C9; CYP2C19 |
hsa00591 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 7.439E-10 | 1.153E-08 | CYP2C9; CYP1A2; CYP3A4; CYP2C19 |
hsa00830 | Retinol metabolism_Homo sapiens_hsa00830 | 3.868E-06 | 2.398E-05 | CYP2C9; CYP1A2; CYP3A4 |
hsa00980 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 3.373E-08 | 3.486E-07 | CYP2C9; CYP2D6; CYP1A2; CYP3A4 |
hsa00982 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.048E-10 | 3.250E-09 | CYP2C9; CYP2D6; CYP1A2; CYP3A4; CYP2C19 |
hsa00983 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 2.277E-02 | 3.715E-02 | CYP3A4 |
hsa01100 | Metabolic pathways_Homo sapiens_hsa01100 | 2.276E-03 | 5.426E-03 | CYP2C9; CYP1A2; CYP2C19; CYP3A4 |
ICD10 Disease Category | Disease Name | ICD10 Code | Linked Targets |
---|---|---|---|
A00-B99: Certain infectious and parasitic diseases | Bacterial infections | A00-B99 | DRD2; CYP2C9 |
A00-B99: Certain infectious and parasitic diseases | Malaria | B54 | CYP2D6 |
C00-D49: Neoplasms | Inflammatory disease | C11, C44, K75.9, M00-M25 | DRD2 |
C00-D49: Neoplasms | Breast cancer | C50 | DRD2 |
C00-D49: Neoplasms | Non-small cell lung cancer | C33-C34 | DRD2 |
C00-D49: Neoplasms | Pancreatic cancer | C25 | F3 |
D50-D89: Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism | Idiopathic thrombocytopenic purpura | D69.3 | DRD2 |
E00-E89: Endocrine, nutritional and metabolic diseases | Type 2 diabetes | E11 | DRD1 |
E00-E89: Endocrine, nutritional and metabolic diseases | Hyperprolactinemia | E22.1 | DRD2 |
E00-E89: Endocrine, nutritional and metabolic diseases | Acromegaly | E22.0 | DRD2 |